PIs. Ahhh the ever-so-important private investigators.
Err...I mean protease inhibitors.
You may recall that we've already discussed protease inhibitors in our post on Hepatitis C.
Read MorePIs. Ahhh the ever-so-important private investigators.
Err...I mean protease inhibitors.
You may recall that we've already discussed protease inhibitors in our post on Hepatitis C.
Read MoreWhen I was finishing up pharmacy school (2013), the landscape of Hep-C therapy was drastically changing. Two new drugs, boceprevir and telaprevir, were fresh on the market and were "game changers" according to any and everyone. In fact--I presented these new protease inhibitors (in all their majesty) during my residency interviews.
Now it's 2016 and they're both gone.
Read More